What's the relationship between MultiStem and traumatic brain injury, Biojax? I hadn't read or heard anything about this, but I'm certainly interested.
Also, that's a good post. Folks relatively new to the stock often need to be informed about the umpteen pies that Athersys has its fingers in. Moreover, another significant catalyst is a less visible one than the company's R&D. It's research firms, analysts, and brokerages discovering Athersys as an evocative speculative buy with an unusually attractive risk/reward ratio and drummimg up new buyers who are learning about the company for the first time.
Rocket it will, just like the last several times it punched through 2.20. Everybody knows that the infallibility of charts is why chartists are rich and that those who look at mere fundamentals have chopped liver. So I say forget such delusionary chimeras as a promising pipeline. All one needs is graph paper and a ruler to determine when to buy, when to sell, and, ultimately, how to spend the rumbling cascade of cash that threatens the livingroom furniture.
Sentiment: Strong Buy
Wahnton, you are being diplomatically very kind to the man. You used "spammy." I like that. It's certainly more gentle than saying "desperate."
Sentiment: Strong Buy
I think that when your posts are objectively informative that they are really helpful. I can't say the same, though, about what seems to me excessive cheerleading. Ironically, such frequent calls to buy ATHX and declarations about Athersys's positive future undermine your credibility. Your informative posts (and I include the SA blogs) are encouragement enough. Throw away the pom poms and stick with the info.Little more is needed.
What's so great, Jausting, about yet another delay in reporting initial UC trial results from Q1 to Q2? It seems that these delays get pushed ahead on a regular basis.
I'm guessing that Jan. provides some nice Linn rebound. But as we move into the end of Dec. there could be some anticipatory buying as well. The company is certainly stronger as a result of the merger and should soon begin (maybe even today?) to reflect that despite the remaining headwinds of tax-loss selling.
And just in case a few folks have been in a similar investment boat as mine (uniniterested parties, please tune out), I did some major juggling between my IRAs (wife's included) and regular account in light of LNCO finally selling at a discount to LINE. The upshot is that I sold some bond funds in the reg. acct. and used the cash to buy LNCO. Then I sold a roughly equivalent sum of LINE in the IRAs and bought back the same amount of those funds (commission-free from TDAmeritrade) in the IRAs. On avg. the difference between LNCO and LINN was $1.15. So I still don't have to deal with K-1s, but the big motivator for me was that LinnCo expects to have continued return of capital in future years. And because some years back when the market was like the wild west, I made some big trading profits. But when the party ended, I gave back about half the money and now have an embarrassingly large tax-loss carryforward. That protects me from capital gains on the cost-basis reduction when I ultimately sell LNCO, if I do. So all the ROC will be non-taxable, and because of the loss carryforwards non-deferred, in effect, also. Until the LNCO cost basis hits zero, of course. Finall, it wouldn't surprise me to se LNCO recover its premium over Linn because of aversion to K-1s and tax deferral, despite many investors who don't mind these at all.
You're being overly pessimistic, Sandra. Linn's finances are much improved as is the safety of its high distribution. Moreover, this is the time of year for tax-loss selling and Linn, unfortunately, is a prime candidate. Hang in for what's likely to be a January bounce. As for a PPS of 26, Linn's in fine shape now and doesn't at all seem the kind of stock that'd pay 11%+. The high dist. becomes a safety net of sorts.
How's that going to happen after Linn said they'd be reconsidering the increase in light of the change from 1.25X to 1.68X, meaning lots more shares out to receive distribution money. The company's going to need some time, I think, to determine how things are working out with the Berry acquisition and the Permian Basin purchase. My hope is that Linn takes a conservative course in the matter of a distribution increase, as their financial health should be the primary consideration.
Wallstreet, since when does the market owe anyone a reward? What you received for remaining long were generous distributions. You really believed in what "everyone was saying"?
I suggest that you hold off on rubbing your face with ashes and wait for Jan., Feb., and March to determine if the current turbulence isn't a short-term affair. Linn Energy is financially better off now and the distribution safer than it's been in a while. Keep in mind that a company isn#$%$ stock and a stock isn't the company. (And this auction market isn't rigged. It simply is what it is. Gotta face up to it.)
There is some talk of shorting on the board. Could anyone here cite a U.S. brokerage that will allow a retail customer to short a stock under $5? (And I don't mean shorting against the box.) I'd like to phone to verify. So far I've been unable to find any, even though numerous posters on penny stock boards are confident that they abound.
Keep in mind that orphan-drug status facilitates trials and a bit more. It doesn't mean that the company can immediately begin monetizing their product. But it does signify expanding credibility for MultiStem, which from an investor standpoint is excellent news. So if you're a longer-term investor I'd suggest not worrying about pennies or whether the stock is instantly reacting to anything but to think in terms of potential dollars while paying far more attention to the calendar rather than the clock.
Riaguy, the merger is all in units and shares, the amount of which aren't altered by the going price of the units/shares. Former Berry holders will still receive the same amount of LNCO shares as would have been the case several weeks ago when LNCO was higher. There will be no actual money saved by Linn. Berry's debt will be assumed and Linn will have to pay the the monthly distribution without regard to LNCO's price.